Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation

Cells(2024)10.3390/cells13050463Source: DataRank Database

Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.82)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Hossein Arefanian ORCID,Ashraf Al Madhoun ORCID,Fatemah Bahman ORCID,Sardar Sindhu ORCID,Halemah AlSaeed ORCID

Live enrichment

PubMed:38474427 PMC:PMC10931069 OpenAlex:https://openalex.org/W4392499109

Kuwait Foundation for the Advancement of Sciences (KFAS)

Grant: RA-040-2021

Kuwait Foundation for the Advancement of Sciences (KFAS)

Grant: P01 CA97132

NCI NIH HHS

Grant: P01 CA097132

NCI NIH HHS

Grant: R01 CA218678

NIGMS NIH HHS

Grant: R35 GM118128

National Institutes of Health

Grant: 5P01CA097132-02

Sphingolipids in Cancer Therapy and Angiogenesis

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/13/5/463/pdf?version=1709732268

publisherhttps://www.mdpi.com/2073-4409/13/5/463/pdf?version=1709732268

publisherhttps://www.mdpi.com/2073-4409/13/5/463/pdf

journalhttps://doi.org/10.3390/cells13050463

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38474427

Fields of Study

Sphingolipid Metabolism and SignalingLiver Disease Diagnosis and TreatmentEndoplasmic Reticulum Stress and Disease0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsEsterasesInflammationMice, Inbred C57BLObesitySphingomyelin PhosphodiesteraseMiceNon-alcoholic Fatty Liver Disease

Keywords

SteatosisFatty liverLipid metabolismInflammationBiologyHepatocyteInternal medicineEndocrinologyMedicineBiochemistryDiseaseLipotoxicityNafldSmpd3Nsmase2<i>Smpd3</i>QH573-671EsterasesBiology and Life SciencesArticleEndocrinology and MetabolismMice, Inbred C57BLMiceSphingomyelin PhosphodiesteraseNon-alcoholic Fatty Liver DiseaseAnimalsObesityCytology

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Good health and well-being